Fu-neng Jiang

Guangdong Key Laboratory Of Clinical Molecular Medicine And Diagnostics
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma.

A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma.

Journal: Nature communications

Published: December 18, 2023

Retraction Note: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.

Retraction Note: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.

Journal: Molecular cancer

Published: March 21, 2023

CRISPR/Cas9 (D10A) nickase-mediated Hb CS gene editing and genetically modified fibroblast identification.

CRISPR/Cas9 (D10A) nickase-mediated Hb CS gene editing and genetically modified fibroblast identification.

Journal: Bioengineered

Published: January 26, 2023

Genome-Wide CRISPR-Cas9 Screening and Identification of Potential Genes Promoting Prostate Cancer Growth and Metastasis.

Genome-Wide CRISPR-Cas9 Screening and Identification of Potential Genes Promoting Prostate Cancer Growth and Metastasis.

Journal: Current cancer drug targets

Published: October 20, 2021

The study of multiple diagnosis models of human prostate cancer based on Taylor database by artificial neural networks.

The study of multiple diagnosis models of human prostate cancer based on Taylor database by artificial neural networks.

Journal: Journal of the Chinese Medical Association : JCMA

Published: March 29, 2020

Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.

Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.

Journal: Molecular cancer

Published: August 08, 2019

Increasing of FKBP9 can predict poor prognosis in patients with prostate cancer.

Increasing of FKBP9 can predict poor prognosis in patients with prostate cancer.

Journal: Pathology, research and practice

Published: August 05, 2019

Increased intracellular Cl- concentration mediates Trichomonas vaginalis-induced inflammation in the human vaginal epithelium.

Increased intracellular Cl- concentration mediates Trichomonas vaginalis-induced inflammation in the human vaginal epithelium.

Journal: International journal for parasitology

Published: December 13, 2018

Functional classification of prostate cancer‑associated miRNAs through CRISPR/Cas9‑mediated gene knockout.

Functional classification of prostate cancer‑associated miRNAs through CRISPR/Cas9‑mediated gene knockout.

Journal: Molecular medicine reports

Published: May 06, 2018

Expression of PD-L1 in tumor-associated nerves correlates with reduced CD8+ tumor-associated lymphocytes and poor prognosis in prostate cancer.

Expression of PD-L1 in tumor-associated nerves correlates with reduced CD8+ tumor-associated lymphocytes and poor prognosis in prostate cancer.

Journal: International journal of cancer

Published: April 07, 2018

BACH1 promotes the progression of human colorectal cancer through BACH1/CXCR4 pathway.

BACH1 promotes the progression of human colorectal cancer through BACH1/CXCR4 pathway.

Journal: Biochemical and biophysical research communications

Published: February 12, 2018

Elevated Expression of DLG1 Is Associated with Poor Prognosis in Patients with Colorectal Cancer.

Elevated Expression of DLG1 Is Associated with Poor Prognosis in Patients with Colorectal Cancer.

Journal: Annals of clinical and laboratory science

Published: December 22, 2017

Showing 1-12 of 38

Last Updated: 09/26/2026